BioPlus Completes Acquisition of Site in Seongbonsandan Industrial Complex, Chungbuk
[Asia Economy Reporter Hwang Yoon-joo] BioPlus announced on the 18th that it has completed the acquisition of a 45,837㎡ site within the Seongbon Industrial Complex in Eumseong-gun, Chungcheongbuk-do.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- NVIDIA Reports $81.6 Billion in Q1 Revenue, Surpassing Expectations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
BioPlus explained that this is "to secure a business (production) site for business expansion in the field of biological preparations [botulinum toxin, obesity treatment (GLP-1 injection), virus treatment] and for the expansion of the hyaluronic acid-based biomaterial application product line."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
